Upgrade to SI Premium - Free Trial

Guggenheim Starts Sage Therapeutics (SAGE) at Buy

February 22, 2019 7:16 AM
Guggenheim analyst Yatin Suneja initiates coverage on Sage Therapeutics (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

New Coverage

Next Articles